Login to Your Account


MUNICH – As BIO-Europe drew to a close, the ongoing funding gap in Germany loomed large. .

MUNICH – The value of up-front payments in global biopharma licensing agreements is still climbing, and global M&A spending on R&D-stage companies so far in 2015 is the best in more than a decade.

LONDON – The EMA has opened a public consultation on the use of digital sensors embedded within pills to measure adherence and physiologic response, after concluding this form of tracking should be given its seal of approval as a biomarker in clinical trials.
More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: